Zimmer Biomet Holdings Inc (ZBH.N)
ZBH.N on New York Stock Exchange
113.29USD
8:39pm IST
113.29USD
8:39pm IST
Change (% chg)
$-1.60 (-1.39%)
$-1.60 (-1.39%)
Prev Close
$114.89
$114.89
Open
$114.89
$114.89
Day's High
$114.89
$114.89
Day's Low
$112.69
$112.69
Volume
30,296
30,296
Avg. Vol
274,349
274,349
52-wk High
$133.45
$133.45
52-wk Low
$104.28
$104.28
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 1.72 | December | 16 Jul 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 9 | 11 | 11 |
| (2) OUTPERFORM | 8 | 8 | 8 | 9 |
| (3) HOLD | 10 | 9 | 9 | 9 |
| (4) UNDERPERFORM | 1 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.15 | 2.00 | 1.93 | 1.93 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 22 | 1,854.57 | 1,878.10 | 1,812.67 | 1,928.11 |
| Quarter Ending Dec-18 | 22 | 2,120.02 | 2,143.00 | 2,079.34 | 2,142.06 |
| Year Ending Dec-18 | 24 | 7,987.80 | 8,022.00 | 7,883.22 | 8,116.52 |
| Year Ending Dec-19 | 25 | 8,146.33 | 8,268.60 | 7,910.00 | 8,379.96 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 24 | 1.72 | 1.78 | 1.63 | 2.15 |
| Quarter Ending Dec-18 | 24 | 2.13 | 2.21 | 2.02 | 2.57 |
| Year Ending Dec-18 | 27 | 7.64 | 7.73 | 7.38 | 9.22 |
| Year Ending Dec-19 | 27 | 8.00 | 8.28 | 7.48 | 10.01 |
| LT Growth Rate (%) | 5 | 5.60 | 7.00 | 4.20 | 9.70 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 1,980.26 | 2,017.60 | 37.34 | 1.89 |
| Quarter Ending Dec-17 | 2,028.68 | 2,074.30 | 45.62 | 2.25 |
| Quarter Ending Sep-17 | 1,830.00 | 1,818.10 | 11.90 | 0.65 |
| Quarter Ending Jun-17 | 1,952.17 | 1,954.40 | 2.23 | 0.11 |
| Quarter Ending Mar-17 | 1,960.73 | 1,977.30 | 16.57 | 0.85 |
| Earnings (per share) | ||||
| Quarter Ending Mar-18 | 1.89 | 1.91 | 0.02 | 1.29 |
| Quarter Ending Dec-17 | 2.10 | 2.10 | 0.00 | 0.10 |
| Quarter Ending Sep-17 | 1.74 | 1.72 | 0.02 | 1.17 |
| Quarter Ending Jun-17 | 2.10 | 2.08 | 0.02 | 0.77 |
| Quarter Ending Mar-17 | 2.11 | 2.13 | 0.02 | 0.97 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1,854.57 | 1,856.90 | 1,858.80 | 1,858.53 | 1,928.11 |
| Quarter Ending Dec-18 | 2,120.02 | 2,123.22 | 2,125.18 | 2,125.38 | 2,142.06 |
| Year Ending Dec-18 | 7,987.80 | 7,994.76 | 7,999.19 | 7,999.33 | 8,116.52 |
| Year Ending Dec-19 | 8,146.33 | 8,154.40 | 8,164.58 | 8,169.02 | 8,379.96 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1.72 | 1.73 | 1.73 | 1.73 | 2.15 |
| Quarter Ending Dec-18 | 2.13 | 2.13 | 2.14 | 2.14 | 2.57 |
| Year Ending Dec-18 | 7.64 | 7.65 | 7.67 | 7.67 | 9.22 |
| Year Ending Dec-19 | 8.00 | 8.01 | 8.06 | 8.05 | 10.01 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-18 | 0 | 2 | 0 | 2 |
| Quarter Ending Dec-18 | 0 | 2 | 0 | 2 |
| Year Ending Dec-18 | 0 | 2 | 0 | 2 |
| Year Ending Dec-19 | 0 | 2 | 0 | 2 |
| Earnings | ||||
| Quarter Ending Sep-18 | 1 | 1 | 1 | 2 |
| Quarter Ending Dec-18 | 0 | 2 | 0 | 3 |
| Year Ending Dec-18 | 0 | 2 | 0 | 3 |
| Year Ending Dec-19 | 0 | 1 | 0 | 3 |
Earnings vs. 
Estimates- BRIEF-Zimmer Biomet Reports Q1 Earnings Per Share $0.85
- BRIEF-Zimmer Biomet Announces FDA Clearance And First Surgical Case Of The Persona Trabecular Metal Tibia
- BRIEF-Zimmer Biomet Says CEO Hanson's FY'17 Total Compensation Was $16.3 Mln
- BRIEF-Zimmer Biomet Holdings Files For Offering Of Floating Rate Notes Due 2021
- BRIEF-Zimmer Biomet Holdings Reports Q4 EPS Of $6.16